Rheumatoid Arthritis Upper Respiratory Multi-Omics

Overview

About this study

We aim to identify multi-omic features associated with RA development, diagnosis, and treatment.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age 16 or older and ability to consent.
- RA Cases:
  - Required to meet ACR/EULAR 2010 criteria for RA.
- Healthy Controls:
  - Adults residing in the same household as a RA case subject.
  - Adults in the division of Rheumatology in contact with RA patients.

Exclusion Criteria:

Healthy Controls
- Cannont have a diagnosis of RA.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/12/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Vanessa Kronzer, M.D.	Open for enrollment	Contact information: Emily Oldham (507) 293-1083 Oldham.Emily@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Vanessa Kronzer, M.D.

Open for enrollment

Contact information:

Emily Oldham

(507) 293-1083

Oldham.Emily@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials